Background Cangrelor, a nonthienopyridine adenosine triphosphate analogue, is an intravenous blocker of the adenosine diphosphate receptor P2Y12. This agent might have a role in the treatment of patients who require rapid, predictable, and profound but ...
Background Intravenous cangrelor, a rapid-acting, reversible adenosine diphosphate (ADP) receptor antagonist, might reduce ischemic events during percutaneous coronary intervention (PCI). Methods In this double-blind, placebo-controlled study, we ...
Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings. Priscilla Wald, a professor of English at Duke University, was motivated to write Contagious by her "conviction that an ...
Help us add to our database, by linking this writer their entry in Wikipedia or Source Watch, or by suggesting that we remove it from our index.